MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, KRYS has $1,396,967K in assets. $120,238K in debts. $501,313K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
945.94%
Quick Ratio
906.38%
Cash Ratio
465.03%
Debt to Asset Ratio
8.61%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Short-term investments
    • Long-term investments
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Retained earnings
    • Accrued rebates
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
501,313 496,304 392,604 353,829
Short-term investments
322,092 331,487 338,465 328,157
Accounts receivable, net
127,022 127,425 129,633 111,439
Inventory
42,646 40,475 37,632 31,041
Prepaid taxes
10,642 14,006 10,103 -
Prepaid expenses and other current assets
16,026 14,905 17,213 16,881
Total current assets
1,019,741 1,024,602 925,650 841,347
Property and equipment, net
153,582 150,776 148,871 150,388
Long-term investments
193,485 128,066 133,113 138,807
Right-of-use assets
7,035 7,239 7,447 7,655
Deferred tax asset, net of valuation allowance
22,824 22,824 24,680 -
Other non-current assets
300 287 333 197
Total assets
1,396,967 1,333,794 1,240,094 1,138,394
Accounts payable
4,089 3,238 2,097 7,124
Current portion of lease liability
1,800 1,771 1,698 1,617
Accrued rebates
70,717 58,181 55,769 51,638
Accrued expenses and other current liabilities
31,196 39,752 31,704 26,517
Total current liabilities
107,802 102,942 91,268 86,896
Lease liability
7,312 7,568 7,813 8,064
Other long-term liabilities
5,124 3,724 3,137 2,787
Total liabilities
120,238 114,234 102,218 97,747
Additional paid-in capital
1,198,257 1,194,261 1,164,013 1,146,092
Accumulated other comprehensive (loss) gain
-1,623 1,136 1,100 1,157
Retained earnings
80,095 24,163 -27,237 -106,602
Total stockholders equity
1,276,729 1,219,560 1,137,876 1,040,647
Total liabilities and stockholders equity
1,396,967 1,333,794 1,240,094 1,138,394
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$501,313K Short-term investments$322,092K Accounts receivable, net$127,022K Inventory$42,646K Prepaid expenses andother current assets$16,026K Prepaid taxes$10,642K Total current assets$1,019,741K Long-term investments$193,485K Property and equipment,net$153,582K Deferred tax asset, net ofvaluation allowance$22,824K Right-of-use assets$7,035K Other non-currentassets$300K Total assets$1,396,967K Total liabilities andstockholders equity$1,396,967K Total stockholdersequity$1,276,729K Total liabilities$120,238K Accumulated othercomprehensive (loss) gain-$1,623K Additional paid-in capital$1,198,257K Retained earnings$80,095K Total currentliabilities$107,802K Lease liability$7,312K Other long-termliabilities$5,124K Accrued rebates$70,717K Accrued expenses andother current...$31,196K Accounts payable$4,089K Current portion of leaseliability$1,800K

Krystal Biotech, Inc. (KRYS)

Krystal Biotech, Inc. (KRYS)